Compare ABEO & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | RFMZ |
|---|---|---|
| Founded | 1974 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.5M | 290.5M |
| IPO Year | 2005 | 2020 |
| Metric | ABEO | RFMZ |
|---|---|---|
| Price | $2.37 | $12.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $18.38 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 88.8K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $731.38 | N/A |
| Revenue Next Year | $129.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $2.30 | $11.31 |
| 52 Week High | $7.65 | $13.70 |
| Indicator | ABEO | RFMZ |
|---|---|---|
| Relative Strength Index (RSI) | 17.47 | 50.43 |
| Support Level | N/A | $11.84 |
| Resistance Level | $5.77 | $12.19 |
| Average True Range (ATR) | 0.30 | 0.18 |
| MACD | -0.19 | 0.03 |
| Stochastic Oscillator | 2.67 | 44.32 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.